The trade pushes IFM to 32 per cent ownership in the toll roads owner, up from 26 per cent this time last year.

Novartis is to buy US biotech IFM Tre in a deal worth up to $1.575 billion, adding a potential drug for the fatty liver disease known as NASH to its pipeline. IFM Tre is a subsidiary of cancer ...

a subsidiary of Boston-based IFM Therapeutics, in a deal worth up to $1.6 billion. The purchase gives Novartis a portfolio of antagonists of NLRP3, a drug target that is being hotly pursued by big ...

IFM Investors chief executive Brett Himbury says the chief investment officers of the country's superannuation funds have increased their appetite for unlisted assets as a way to overcome the most ...

(Reuters) - Asset manager IFM Investors will acquire pipeline operator Buckeye Partners LP in an all-cash deal for $6.5 billion, they said in a joint statement on Friday. Under the terms of the ...

The deal is expected to close in the first quarter of this year Marathon Capital acted as financial advisor to GreenGas on the transaction IFM Investors has $143 billion under management as of ...

Infrastructure specialist IFM Investors seeks to help countries such as the U.S. and Australia expand their renewable-fuel industries, as the firm continues to follow a strategy of backing assets ...

SYDNEY, Sept 7 (Reuters) - Australia's IFM Investors will end its exposure to thermal coal by 2030 due to climate change risks, the A$170 billion ($126 billion) investment manager said on Tuesday ...